Nisoldipine versus isosorbide dinitrate in coronary heart disease: Results of a double-masked study

Clinical Therapeutics

Volumn 18, Issue 3, 1996, Pages 448-459

  Heublein, B ^a   Amende, I ^b   Blanke, P M ^c   Baunack Frost, A R ^c   Breuer, H W M ^d  

^a DRK Clementinenhaus   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c BAYER AG   (Germany)

^d St Carolus Krankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE DINITRATE; NISOLDIPINE;

ADULT; AGED; ALLERGY; ARTICLE; BICYCLE ERGOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; SUSTAINED RELEASE PREPARATION; VERTIGO;

EID: 0029951027     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80025-7     Document Type: Article

References (24)

1. Hagel J, Pasz T, Kampe P. Nisoldipine in stable angina. A comparative study versus sustained-release isosorbide mononitrate. Acta Ther. 1990;16:299-311.
2. Klein W, Brandt D, Fluch N, Sterz F. Nisoldipine versus mononitrate in stable angina. In: Hugenholtz PG, Meyer J, eds. Nisoldipine 1987. Berlin: Springer Verlag; 1987:228-232.
3. Felder K, Knaup G. Comparison of nisoldipine with isosorbide dinitrate in coronary artery disease. Acta Ther. 1990;16: 17-27.
4. Lopez LM, Rubin MR, Holland JP, Mehta JL. Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients. Am Heart J. 1985;110:991-996.
5. Deeg P, Blanke P, Knaup G, Pröve A. Nisoldipin bei koronarer Herzkrankheit: Ergebnisse einer multizentrischen Studie an 1093 Patienten. Z Klin Med. 1992;47: 114-118.
6. Knaup G, Cagatay M, Blanke P. Zur antianginösen Wirksamkeit und Verträglichkeit von Nisoldipin: Daten einer Anwendungsbeobachtung an 8704 Patienten mit koronarer Herzkrankheit. Z Klin Med. 1992;47:124-128.
7. Parker JO. Nitrates and angina pectoris. Am J Cardiol. 1993;72(Suppl):3C-8C.
8. Thadani V. Role of nitrates in angina pectoris. Am J Cardiol. 1992;70(Suppl): 43B-53B.
9. Mangione NJ, Glasser SP. Phenomenon of nitrate tolerance. Am Heart J. 1994;128: 137-146.
10. Olsson G, Allgen J. Prophylactic nitrate therapy in angina pectoris - is there an optimal therapeutic regimen? Br J Clin Pharmacol. 1992;34(Suppl):19S-23S.
11. Heusch G. Ischemia-selectivity: A new concept of cardioprotection by calcium antagonists. Basic Res Cardiol. 1994; 89:2-5.
12. Pouleur H, van Eyll C, Gurnée O, Rousseau MF. Analysis of the mechanisms underlying the changes in left ventricular filling dynamics during oral nisoldipine therapy in patients with anterior myocardial infarction. Eur Heart J. 1992;13: 952-959.
13. Janis RA, Shrikhande AV, Greguski R, et al. Review of nisoldipine binding studies. In: Hugenholtz PG, Meyer J, eds. Nisoldipine 1987. Berlin: Springer Verlag; 1987:27-35.
14. Aschenberg W, Nienaber C, Spielmann R, Bleifeld W. Vergleich der akuten hämodynamischen Wirkung von Nisoldipin (Bay k 5552) und Nifedipin bei Patienten mit ischämisch bedingter linksventrikulärer Funktionsstörung. Z Kardiol. 1988;77: 238-244.
15. Lewis BS, Shefer A, Flugelman MY, et al. Improvement in diastolic left ventricular function with nisoldipine in patients with ischemic heart failure. In: Lichtlen PR, Hugenholtz PG, eds. Nisoldipine. New York: F.K. Schattauer Verlag; 1988:82-94.
16. Farberg CD, Psaty BM, Meyer JV. Nifedipine - dose related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
17. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
18. Barnett AA. FDA committee rules calcium-channel blockers safe. Lancet. 1996; 347:313.
19. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction - a hypothesis formulated but not yet tested. JAMA. 1995;274:654-655.
20. Kloner RA. Nifedipine in ischemic heart disease. Circulation. 1995;92:1074-1078.
21. Messerli FH. Are calcium antagonists safe? Lancet. 1995;346:767-768.
22. Opie LH, Messerli FH. Nifedipine and mortality - grave defects in the Dossier. Circulation. 1995;92:1068-1073.
23. Klein HH, Kreuzer H. Effect of nisoldipine on electrophysiological parameters in man. In: Hugenholtz PG, Meyer J, eds. Nisoldipine 1987. Berlin: Springer Verlag; 1987:89-93.
24. Lofdahl P. Compliance as a factor in the development of nitrate tolerance: A patient investigation. J Int Med Res. 1993; 21:51-57.